RepliCel Life Sciences Inc (OTCQB:REPCF)

0.277
Delayed Data
As of Apr 20
 -0.01 / -3.48%
Today’s Change
0.26
Today|||52-Week Range
0.77
-10.65%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2013

2014

2015

2016
AssetsCash1.8M462.0K126.6K45.3K
 
 
 
 
 
Short Term Investment Cash1.5M-1.3M-280.9K-86.8K
 
 
 
 
 
Cash & Short Term Investments1.8M1.8M126.6K1.1M
 
 
 
 
 
 
ReceivablesReceivables23.1K25.1K18.6K49.3K
 
 
 
 
 
 
InventoriesInventories0.00--0.000.00--
 
Current AssetsOther Current Assets43.8K44.2K139.1K176.0K
 
 
 
 
 
Current Assets1.9M1.8M284.2K1.4M
 
 
 
 
 
 
Total AssetsProperty, Plant and Equipment - Gross41.1K46.5K40.3K41.8K
 
 
 
 
 
Depreciation-19.1K-24.1K-25.1K-30.3K
 
 
 
 
 
Other Assets0.000.000.000.00--
Total Assets1.9M1.8M299.4K1.4M
 
 
 
 
 
 
LiabilitiesAccounts Payable347.6K0.000.000.00
 
 
Accrued Expenses----629.8K278.9K
 
 
 
Other Current Liabilities0.00289.3K732.6K463.6K
 
 
 
 
Other Liabilities347.6K289.3K732.6K463.6K
 
 
 
 
 
 
Total LiabilitiesOther Liabilities196.1K0.000.000.00
 
 
Total Liabilities543.8K289.3K732.6K463.6K
 
 
 
 
 
 
EquityMinority Interest0.000.000.000.00--
Preferred Stock0.000.000.000.00--
Common Equity1.4M1.6M-433.2K899.6K
 
 
 
 
 
Total Shareholder Equity1.4M1.6M-433.2K899.6K
 
 
 
 
 
 
Share InformationCommon Shares Outstanding4.8M5.5M6.3M15.7M
 
 
 
 
 
 
Addtl. Info.No data currently available for this section.